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Background: Accumulating evidence indicates that the long non-coding RNA HOTAIR plays a critical role in cancer
progression and metastasis. However, the overall biological role and clinical significance of HOTAIR in gastric
carcinogenesis remains largely unknown.
Methods: HOTAIR expression was measured in 78 paired cancerous and noncancerous tissue samples by real-time
PCR. The effects of HOTAIR on gastric cancer cells were studied by overexpression and RNA interference approaches
in vitro and in vivo. Insights of the mechanism of competitive endogenous RNAs (ceRNAs) were gained from
bioinformatic analysis, luciferase assays and RNA binding protein immunoprecipitation (RIP). The positive HOTAIR/HER2
interaction was identified and verified by immunohistochemistry assay and bivariate correlation analysis.
Results: HOTAIR upregulation was associated with larger tumor size, advanced pathological stage and extensive
metastasis, and also correlated with shorter overall survival of gastric cancer patients. Furthermore, HOTAIR overexpression
promoted the proliferation, migration and invasion of gastric carcinoma cells, while HOTAIR depletion inhibited both cell
invasion and cell viability, and induced growth arrest in vitro and in vivo. In particular, HOTAIR may act as a ceRNA,
effectively becoming a sink for miR-331-3p, thereby modulating the derepression of HER2 and imposing an additional
level of post-transcriptional regulation. Finally, the positive HOTAIR/HER2 correlation was significantly associated with
advanced gastric cancers.
Conclusions: HOTAIR overexpression represents a biomarker of poor prognosis in gastric cancer, and may confer
malignant phenotype to tumor cells. The ceRNA regulatory network involving HOTAIR and the positive interaction
between HOTAIR and HER2 may contribute to a better understanding of gastric cancer pathogenesis and facilitate the
development of lncRNA-directed diagnostics and therapeutics against this disease.
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Gastric cancer is the second leading cause of cancer-
induced death, and is the most common gastrointestinal
malignancy in East Asia, Eastern Europe, and parts of Cen-
tral and South America. In most patients, gastric cancer is
diagnosed at an advanced stage and is accompanied by ma-
lignant proliferation, extensive invasion and lymphatic me-
tastasis. Successful therapeutic strategies are limited and
the mortality is high [1,2]. Long non-coding RNAs
(lncRNAs) have recently gained significant attention in de-
lineating the complex mechanisms underlying malignant
processes such as carcinogenesis, metastasis and drug re-
sistance. Therefore, if we want to fully understand gastric
carcinogenesis, we need to consider this family of regula-
tory transcripts that add a new layer of complexity to
tumor biology.
Although only a small number of functional lncRNAs
have been well characterized to date, they have been
shown to regulate gene expression at various levels, in-
cluding chromatin modification, transcription and post-
transcriptional processing [3,4]. Recently, a new regulatory
mechanism has been identified in which crosstalk between
lncRNAs and mRNAs occurs by competing for shared
microRNAs (miRNAs) response elements. In this case,
lncRNAs may function as competing endogenous RNAs
(ceRNAs) to sponge miRNAs, thereby modulating the de-
repression of miRNA targets and imposing an additional
level of post-transcriptional regulation [5]. In previous
reports, a muscle-specific lncRNA, linc-MD1, has been
reported to be a ceRNA that protects MyoD messenger
RNA (mRNA) from miRNA-mediated degradation [6].
Pluripotency-associated lnc-RoR may function as a key
ceRNA to link the network of miRNAs and core tran-
scription factors, e.g., Oct4, Sox2, and Nanog, in human
embryonic stem cells. Notably, lncRNA HULC is highly
upregulated in liver cancer and plays an important role in
tumorigenesis [7]. In particular, HULC may act as an en-
dogenous ‘sponge’ that down-regulates a series of miRNAs
activities, including miR-372 [8]. We therefore propose
that some lncRNAs may also have roles as ceRNAs, linking
miRNAs and the post-transcriptional network in gastric
pathogenesis.
HOTAIR (Hox transcript antisense intergenic RNA) is
a ~2.2-kb long non-coding RNA transcribed from the
HOXC locus, which can repress transcription in trans of
HOXD in foreskin fibroblasts [9]. As a novel molecule in
the field of tumor biology, HOTAIR initially became well
known for its involvement in primary breast tumors and
breast cancer metastases, wherein elevation of HOTAIR
promoted invasiveness and metastasis [10]. Furthermore,
HOTAIR expression positively correlates with malignant
processes and poor outcome in colorectal cancer, hepa-
tocellular carcinoma, pancreatic cancer and gastrointes-
tinal stromal tumors [11-14]. Recent studies reported thatHOTAIR was upregulated in gastric cancer [15,16]. Never-
theless, the overall biological role and underlying molecular
mechanism of HOTAIR in gastric carcinogenesis remains
largely undefined.
In this study, we report that HOTAIR upregulation is
a characteristic molecular change in gastric cancer and
investigate the biological roles of HOTAIR on the pheno-
types of gastric cancer cells in vitro and in vivo. Moreover,
mechanistic analysis reveals that HOTAIR may function
as a ceRNA to regulate the expression of human epithelial
growth factor receptor 2 (HER2) through competition for
miR-331-3p, thus playing an oncogenic role in gastric
pathogenesis. The present work provides the first evidence
for a positive HOTAIR/HER2 correlation and the cross-
talk between miR-331-3p, HOTAIR and HER2, shedding
new light on the treatment of gastric cancer.Results
HOTAIR expression is upregulated in human gastric
cancer tissues
The level of HOTAIR expression was determined in 78
paired gastric cancer samples and adjacent, histologically
normal tissues by qRT-PCR, and normalized to GAPDH.
HOTAIR expression was significantly upregulated in can-
cerous tissues (mean ratio of 14.35-fold, P < 0.01) compared
with normal counterparts (Figure 1A). Examination of
the correlation between HOTAIR expression and clin-
ical pathological features showed that HOTAIR upregu-
lation was correlated with larger tumor size, advanced
pathological stage, distant metastasis (Figure 1B and C),
lymph node metastasis and tumor cell differentiation
(Table 1). However, HOTAIR expression was not associ-
ated with tumor position or patient gender (Table 1). With
regard to overall survival, patients with high HOTAIR ex-
pression had a significantly poorer prognosis than those
with low HOTAIR expression (P < 0.001, log-rank test;
Figure 1D). These results imply that HOTAIR overexpres-
sion may be useful in the development of novel prognostic
or progression markers for gastric cancer.Manipulation of HOTAIR levels in gastric cancer cells
We next performed qRT-PCR analysis to examine the ex-
pression levels of HOTAIR in various cancer cell lines, in-
cluding gastric, non-small cell lung cancer (NSCLC) and
breast cancer-derived cells. As shown in Figure 2A, of the
four gastric cancer cell lines investigated (MGC-803, SGC-
7901, BGC-823, and AGS), BGC-823 expressed higher
levels of HOTAIR (3.18-fold) than the normal gastric epi-
thelium cell line (GES-1). Similarly, NSCLC cell line, SPC-
A1, showed a 3.73-fold upregulation of HOTAIR over the
normal human bronchial epithelial cell line, 16HBE. The
highly metastatic breast cancer cell line MDA-MB-231
showed a 4.77-fold upregulation of HOTAIR compared
Figure 1 Relative HOTAIR expression in gastric cancer tissues and its clinical significance. (A) Relative expression of HOTAIR in gastric
cancer tissues (n = 78) in comparison with corresponding non-tumor normal tissues (n = 78). HOTAIR expression was examined by qRT-PCR and
normalized to GAPDH expression. Data was presented as fold-change in tumor tissues relative to normal tissues. (B) Examination of the correlation between
HOTAIR expression and clinical pathological features showed that HOTAIR upregulation correlated with larger tumor size and advanced pathological stage.
(C) HOTAIR expression was significantly higher in patients with distant metastasis than in those with non-distant metastasis. (D) Kaplan–Meier overall
survival curves according to HOTAIR expression level. The overall survival of the High-HOTAIR group (n = 39: HOTAIR expression ratio≥median ratio) was
significantly higher than that of Low-HOTAIR group (n = 39; HOTAIR expression ratio≤median ratio; P < 0.001, log-rank test). *P < 0.05, **P < 0.01.
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may be frequently upregulated in many tumor cells.
To manipulate HOTAIR levels in gastric cancer cells,
a pCDNA/HOTAIR vector was transfected into SGC-
7901 cells and si-HOTAIR was transfected into BGC-
823 cells, respectively. qRT-PCR analysis of HOTAIR
levels was performed at 48 h post-transfection and re-
vealed that HOTAIR expression was increased 98-fold in
SGC-7901 cells, compared with control cells. However,
in BGC-823 cells, HOTAIR expression was effectively
75% knocked down by si-HOTAIR2, the most effective
siRNA subsequently used in the following experiments
(Figure 2B).Effect of HOTAIR on cell proliferation and apoptosis
in vitro
The significant increase of HOTAIR expression in gas-
tric cancer samples prompted us to explore the possible
biological significance of HOTAIR in tumorigenesis. MTT
assay revealed that cell growth was significantly impaired
in BGC-823 cells transfected with si-HOTAIR, while pro-
liferation of SGC-7901 cells was increased in pCDNA/
HOTAIR transfected cells compared with respective
controls (Figure 2C). Similarly, the result of colony-
formation assay revealed that clonogenic survival was
decreased following inhibition of HOTAIR in BGC-823
cells (Figure 2D).
Table 1 Correlation of the expression of HOTAIR with
clinicopathologic features
Clinicopathologic features n (%) Relative expression
of HOTAIRa
P-valueb
Gender P = 0.62
Male 50 (64) 12.21 (0.97-17.53)
Female 28 (36) 15.01 (7.34 -19.52)
Site of tumor P = 0.910
Distal third 18 (23) 9.1 (1.37-14.12)
Middle third 20 (26) 7.96 (2.55-9.72)
Proximal stomach 40 (51) 7.76 (1.24-13.58)
Differentiation P = 0.045
Poor 56 (72) 15.6 (6.25-20.36)
High/moderate 22 (28) 8.1 (0.98-11.14)
Lymph node Metastasis P = 0.005
N0 10 (13) 1.14 (0.75-1.42)
N1 11 (14) 3.44 (1.15-4.85)
N2 29 (37) 11.99 (7.15-14.77)
N3 28 (36) 32.58 (7.34-36.27)
Metastatic disease P = 0.029
M0 64 (82) 9.35 (2.53-33.64)
M1 14 fig 28.82 (16.39-39.39)
aMedian of relative expression, with 25th-75th percentile in parentheses.
bP < 0.05 was considered significant (Mann–Whitney U test between 2 groups
and Kruskall-Wallis test for 3 groups).
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tor to cell growth inhibition, we performed Hoechst stain-
ing and flow-cytometric analysis of si-HOTAIR-treated
BGC-823 cells. The data showed that the number of cells
with condensed and fragmented nuclei indicating the frac-
tion of early apoptotic cells was significantly higher in
si-HOTAIR-treated BGC-823 cells compared with si-
NC-treated cells (Figure 3A and B). In addition, we found
that inhibition of HOTAIR enhanced caspase-3-dependent
apoptosis, demonstrated by western blot analysis of acti-
vated caspase-3 after si-HOTAIR transfection (Additional
file 1: Figure S1). Taken together, these results indicate that
knockdown of HOTAIR suppresses gastric cancer cell pro-
liferation and induces apoptosis in vitro.
HOTAIR promotes migration and invasion of gastric
cancer cells in vitro
Cell invasion is a significant aspect of cancer progression
that involves the migration of tumor cells into contigu-
ous tissues and the dissolution of extracellular matrix
proteins. Here we evaluated cancer cell invasion through
transwell assays. As shown in Figure 3C, the transfection
of HOTAIR siRNA impeded the migratory ability BGC-
823 cells by roughly 66%. A corresponding effect on inva-
siveness was also observed in a parallel invasion assay.
Conversely, transfection of SGC-7901 cells with pCDNA/HOTAIR vector promoted cell migration and invasive-
ness ~1.9-fold (Figure 3D). These data indicate that
HOTAIR has oncogenic properties that can promote a
migratory and invasive phenotype in gastric cancer cells.
HOTAIR promotes tumorigenesis of gastric cancer cells
in vivo
To explore whether the level of HOTAIR expression af-
fects tumorigenesis, BGC-823 cells transduced with the
sh-HOTAIR/pENTR vector (EV) were used in a nude
mice xenograft model. Up to 16 days after knockdown
of HOTAIR, there was a dramatic decrease in tumor
volume and weight in the sh-HOTAIR group compared
with controls (Figure 4A, B and C). Next, immunostain-
ing analysis of the proliferation marker PCNA was per-
formed in resected tumor tissues. In comparison with
that in tumors formed from control cells, sh-HOTAIR-
derived tumors showed significantly reduced PCNA posi-
tivity (Figure 4D). These results suggest that the level of
HOTAIR expression is significantly associated with the
in vivo proliferation capacity of gastric cancer cells.
HOTAIR is a target of miR-331-3P and miR-124
Bioinformatics analysis of miRNA recognition sequences
on HOTAIR revealed the presence of 11 tumor-suppressive
miRNAs binding sites. The HOTAIR cDNA was cloned
downstream of the luciferase gene and named RLuc-HOT
AIR (Figure 5A), then transfected together with various
miRNA-coding plasmids. rno-miR-344 acted as a negative
control. The results showed that luciferase activity was re-
duced by 48% and 31% compared with the empty vector
control when miR-331-3p and miR-124 were expressed, re-
spectively. These data demonstrate that both miR-331-3p
and miR-124 can directly bind to HOTAIR through re-
spective miRNA recognition sites (Figure 5B left panel).
Herein, we chose miR-331-3p as a model miRNA for
further studies. To further confirm that the reduction in
luciferase activity from the RLuc-HOTAIR-WT vector was
due to direct interaction between the miRNA and its puta-
tive binding site, we mutated the miR-331-3p binding site
by site-directed mutagenesis, resulting in RLuc-HOTAIR-
Mut. As expected, suppression of luciferase activity was
completely abolished in this mutant construct compared
with wild-type vector (Figure 5B right panel).
HOTAIR and miR-331-3p both bind with AGO2 in gastric
cancer cells
miRNAs are known to be present in the cytoplasm in
the form of miRNA ribonucleoprotein complexes (miRNPs)
that also contain Ago2, the core component of the RNA-
induced silencing complex (RISC) [17,18]. To test whether
HOTAIR associates with miRNPs, RNA binding protein
immunoprecipitation (RIP) experiments were performed
on BGC-823 cell extracts using antibodies against Ago2.
Figure 2 The level of HOTAIR expression in gastric cancer cells and its effect on cell proliferation in vitro. (A) Results from qRT-PCR
demonstrating HOTAIR expression levels of gastric cancer cell lines (MGC-803, SGC-7901, BGC-823, and AGS) compared with normal gastric
epithelium cell line (GES-1), NSCLC cell line (SPC-A1) compared with normal human bronchial epithelial cell line (16HBE), and breast cancer cell
lines MDA-MB-231 compared with MCF-7. (B) qRT-PCR analyses of HOTAIR expression level following treatment BGC-823 cells with siRNAs targeting
HOTAIR and treatment SGC-7901 cells with pCDNA/HOTAIR vector. (C) MTT assay was performed to determine the proliferation of si-HOTAIR-transfected
BGC-823 cells or pCDNA/HOTAIR-transfected SGC-7901 cells. Data represent the mean ± s.d. from three independent experiments. (D) Colony-forming
growth assay was performed to determine the proliferation of si-HOTAIR transfected BGC-823 cells. Colonies were counted and captured. *P < 0.05
and **P < 0.01.
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qRT-PCR. HOTAIR was preferentially enriched (354-fold)
in Ago2-containing miRNPs relative to control immuno-
globulin G (IgG) immunoprecipitates. Similarly, miRNA-
331-3p was detected at a level 840-fold greater than that
of control anti-IgG. Successful immunoprecipitation of
Ago2-associated RNA was verified by qRT-PCR, using
RIP primers against human FOS included in the RIPAb +
Ago2 kit (Figure 5D, top panel). Moreover, anti-SNRNP70
was used as a positive control for the RIP procedure, and
U1 snRNA was also detected at a level 206-fold greater
than that of anti-IgG (Figure 5D, bottom panel). Thus,
HOTAIR is present in Ago2-containing miRNPs, likely
through association with miRNA-331-3p, consistent with
our bioinformatic analysis and luciferase assays.
HOTAIR controls the miR-331-3p target, HER2
Among the many targets of miR-331-3p, we concentrated
on HER2 since it encodes a transmembrane protein
with a relevant function in carcinogenesis and resistance
to trastuzumab-based therapy [19]. The 3’-UTR of HER2was fused to the luciferase coding region (RLuc-HER2
3’-UTR) and transfected with plasmids encoding miR-
331-3p and an empty plasmid vector. rno-miRNA-344
acted as a negative control. The luciferase assay showed
that miR-331-3p significantly inhibited luciferase activ-
ity (~41% inhibition) of the RLuc-HER2 3’-UTR re-
porter, confirming that HER2 is a target of miR-331-3p.
The RLuc-HER2 3’-UTR construct was subsequently
transfected together with plasmids encoding miR-331-
3p and HOTAIR (pCDNA/HOTAIR). Luciferase assays
indicated that, in the presence of HOTAIR, RLuc-HER2
3’-UTR repression was restored compared with the con-
trol group (Figure 5C). This indicates that HOTAIR acts
as an endogenous ‘sponge’ by binding miR-331-3p, thus
abolishing the miRNA-induced repressing activity on
the HER2 3’-UTR.
Furthermore, the effect of HOTAIR expression on en-
dogenous HER2 protein in combination with modula-
tion of miRNA or lncRNA levels was monitored by the
different approaches shown in Figure 5E: (1) miR-331-3p
overexpression against HER2 in BGC-823 cells; (2)
Figure 3 (See legend on next page.)
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(See figure on previous page.)
Figure 3 The effect of HOTAIR on gastric cancer cell apoptosis, migration and invasion in vitro. BGC-823 cells were transfected with
si-HOTAIR or si-NC, and SGC-7901 cells were transfected with pCDNA/HOTAIR vector or empty vector control. (A) Hoechst staining assay of cell
apoptosis; the percentage of Hoechst-positive nuclei per optical field (at least 50 fields) was determined. (B) The apoptotic rates of cells were
detected by flow cytometry. UL, necrotic cells; UR, terminal apoptotic cells; LR, early apoptotic cells. (C and D) Transwell assays were performed
to investigate changes in cell migration and invasiveness. *P < 0.05 and **P < 0.01.
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HOTAIR overexpression for HER2 in SGC-7901 cells.
Western blot analysis showed that forced expression of
miR-331-3p or knockdown of HOTAIR in BGC-823 cells
triggered a significant silencing effect on endogenous HER2
protein expression. Furthermore, HER2 protein expression
was markedly upregulated after transfection with HOTAIR
in SGC-7901 cells, which demonstrates a relatively low en-
dogenous HOTAIR expression level.
Together these data indicate that by binding miR-331-
3p, HOTAIR acts as a ceRNA for the target HER2 mRNA,
thereby modulating the derepression of HER2 and impos-
ing an additional level of post-transcriptional regulation.Figure 4 Effect of HOTAIR knockdown on tumor growth in vivo. (A) T
transfected with sh-HOTAIR or pENTR vector. Tumor volume was calculated
weight. Values are means of tumor weight ± s.d. (C) qRT-PCR analysis of HO
from BGC-823/sh-HOTAIR cells showed a lower level of PCNA protein than
staining; Lower: immunostaining. *P < 0.05 and **P < 0.01.MiR-331-3p and miR-124 suppress gastric cancer
cells proliferation
To serve as an endogenous sink for target miRNAs, the
abundance of HOTAIR should be comparable to or higher
than miR-331-3p/miR-124. In our study, qRT-PCR ana-
lysis showed that miR-331-3p/miR-124 expression was in-
versely correlated with HOTAIR expression in 20 pairs of
advanced gastric cancers (Figure 6A). To validate whether
miR-331-3p and miR-124 could also inhibit gastric cancer
cell proliferation, we forced their expression in BGC-823
cells using miRNA-encoding plasmids. The expression
levels of miRNA-331-3p and miR-124 transfected into
BGC-823 cells were significantly increased by 36-foldumor growth curves were measured after injection of BGC-823 cells
every 3 days. Data are presented as mean ± s.d. (n = 5). (B) Tumor
TAIR expression in tissues of resected tumors. (D) Tumors developed
tumors developed from BGC-823/pENTR vector cells. Upper: H & E
Figure 5 HOTAIR is a target of miR-331-3P or miR-124 and controls miR-331-3p target. (A) The 11 putative miRNA binding sites in the
HOTAIR sequence. The HOTAIR cDNA containing the putative miRNAs recognition sites was cloned downstream of the luciferase gene and named
RLuc-HOTAIR. (B) Left: The luciferase reporter plasmid (RLuc-HOTAIR) was co-transfected into HEK-293 T cells with the 11 various miRNA-coding plasmids.
Right: the luciferase reporter plasmid containing wild-type or mutant HOTAIR was co-transfected into HEK-293 T cells with miR-331-3p in parallel with an
empty plasmid vector. Luciferase activity was determined using the dual luciferase assay and shown as the relative luciferase activity normalized to renilla
activity. Histogram indicates the values of luciferase measured 48 h after transfection. (C) The 3’-UTR of HER2 was fused to the luciferase coding region
(RLuc-HER2 3’-UTR) and transfected in HEK293T cells with miR-331-3p to confirm HER2 is the target of miR-331-3p. RLuc-HER2 3’-UTR and miR-331-3p
constructs were co-transfected into HEK293T cells with plasmids expressing HOTAIR (pCDNA/HOTAIR) or with a control vector to verify the ceRNA activity
of HOTAIR. rno-miRNA-344 was used as a negative control. Histogram indicates the values of luciferase measured 48 h after transfection. (D) RIP with
mouse monoclonal anti-Ago2, preimmune IgG or 10% input from BGC 823-cell extracts. RNA levels in immunoprecipitates were determined by qRT-PCR.
Top: levels of HOTAIR, miRNA331-3P and FOS RNA were presented as fold enrichment in Ago2 relative to IgG immunoprecipitates. Bottom: relative RNA
levels of U1 snRNA in SNRNP70 relative to IgG immunoprecipitates. Numbers are mean ± s.d. (n = 3). (E) Western blot analysis of HER2 protein level
following treatment of BGC-823 cells with si-HOTAIR or pCDNA/HOTAIR, and SGC-7901 cells with pCDNA/HOTAIR. GAPDH was used as control. *P < 0.05,
**P < 0.01 and N.S. not significant.
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(Figure 6B). Next, MTT and colony-formation assays were
performed to determine cell viability. The results of the
MTT assay and growth curves revealed that cells trans-
fected with miR-331-3p or miR-124 showed significant
growth retardation when compared with cells transfected
with empty vector (Figure 6C). These data indicate that
overexpression of miR-331-3p or miR-124 expression can
arrest gastric cancer cell proliferation, which is consistent
with the results of HOTAIR expression knockdown in
BGC-823 cells.
HER2 is coexpressed with HOTAIR in gastric cancer tissues
The HER2 overexpression rate was reported to be 7–34%
in gastric cancer, and was associated with more aggressivedisease and poorer survival in gastric cancer [19]. We
detected expression of HER2 in 50 advanced gastric cancer
tissues (stage III/IV) selected from the previous 78 gastric
cancer tissues by immunohistochemistry (IHC) and qRT-
PCR analysis. The results of IHC staining showed HER2
protein positivity in 56% of the selected 50 gastric can-
cer tissues. Eighty-six percent of these HER2 positive
samples were from advanced stage III/IV tumors, and
71% displayed high HOTAIR expression (Figure 6D and
Additional file 2: Table S2). Bivariate correlation ana-
lysis showed that expression of HER2 was significantly
correlated with HOTAIR transcript level in gastric cancer
tissues compared with normal counterparts (Figure 6D).
These data indicate that the expression of HER2 is posi-
tively associated with upregulated HOTAIR in gastric
Figure 6 Positive correlation between HOTAIR and HER2 expression and the relevance to miR-331-3p/miR-124 expression levels.
(A) Bivariate correlation analysis of the relationship between HOTAIR expression and miR-331-3p, or miR-124 level. (B) BGC-823 cells were transfected
with plasmids encoding miR-331-3p or miR-124, and qRT-PCR was used to detect the miRNA levels compared with controls (miR-NC). (C) MTT assay
and colony-forming growth assay were performed to determine the proliferation of miR-331-3p or miR-124 transfected BGC-823 cells. (D) Left:
immunostaining of HER2 protein in advanced gastric cancer tissue samples. Upper: immunostaining of HER2 was negative in gastric cancer tissues with
relatively low HOTAIR expression. Lower: immunostaining of HER2 was positive in gastric cancer tissues with relatively high HOTAIR expression. Right:
bivariate correlation analysis of the relationship between HOTAIR and HER2 expression level. *P < 0.05, **P < 0.01.
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of the HER2/HOTAIR interaction might be biologically
significant in human gastric tumorigenesis.
Notably, because of an ongoing phase III/IV trial, the
HER2 overexpression rate detected in the present study
is higher than the previously reported median range. This
increased rate of HER2 overexpression is strongly linked
to poor outcomes for patients with metastatic and high-
grade localized gastric cancers, thereby highlighting the
importance of HER2 in gastric cancer development and
metastasis.
Discussion
LncRNAs, which are more than 200 nucleotides in length
with limited protein-coding capacity, are often expressed in
a disease-, tissue- or developmental stage-specific manner,indicating specific functions for lncRNAs in development
and diseases and making these molecules attractive thera-
peutic targets [20-22]. A number of recent papers have re-
vealed that dysregulation of these lncRNAs may also affect
the regulation of the eukaryotic genome and provide a cel-
lular growth advantage, resulting in progressive and uncon-
trolled tumor growth [23-25]. Therefore, lncRNAs may
provide a missing piece of the otherwise well-known onco-
genic and tumor suppressor network puzzle.
In this study, we tested the expression of HOTAIR
in gastric carcinoma samples and their surrounding
non-tumorous tissues. We also identified the function
of HOTAIR in gastric carcinoma cells by applying gain-
and loss-of-function approaches. The results demonstrated
that HOTAIR was upregulated in gastric carcinoma tissues
in comparison with adjacent normal gastric tissues, and
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size, advanced pathological stage and extensive metastasis.
Moreover, the overall survival time of patients with lower
HOTAIR expression levels was significantly longer than
that of patients with moderate or strong HOTAIR expres-
sion levels. Furthermore, HOTAIR overexpression pro-
moted the proliferation, migration and invasion of gastric
carcinoma cells, while HOTAIR depletion inhibited cell in-
vasion and cell viability, and induced growth arrest both
in vitro and in vivo. Additionally, HOTAIR suppression led
to the promotion of gastric cell apoptosis. These findings
suggest that HOTAIR plays a direct role in the modulation
of multiple oncogenic properties and gastric cancer pro-
gression, stimulating new research directions and thera-
peutic options considering HOTAIR as a novel prognostic
marker and therapeutic target in gastric cancer.
The importance of lncRNAs in human disease may be
associated with their ability to impact cellular functions
through various mechanisms. In this study, as far as the
mechanism of HOTAIR is concerned, it is worth men-
tioning that subcellular localization analysis of HOTAIR
by RNA fluorescence in situ hybridization assay demon-
strates the localization of HOTAIR to both the nucleus
and the cytoplasm [24]. It is evident that nuclear HOTAIR
can target polycomb repressive complex 2, altering H3K27
methylation and gene expression patterns across the gen-
ome [10,11]. Recent work reported a scaffold function for
HOTAIR in the cytoplasm as an inducer of ubiquitin-
mediated proteolysis [26]. Nevertheless, the tumorigenic
properties and mechanistic heterogeneity of HOTAIR, and
particularly those of the cytoplasmic form, are far from be-
ing fully elucidated.
Inspired by the ‘competitive endogenous RNAs’ regula-
tory network and emerging evidence that suggests that
lncRNAs may participate in this regulatory circuitry, we
hypothesized that HOTAIR may also serve as a ceRNA
and so we searched for potential interactions with miR-
NAs. In support of this notion, we employed bioinfor-
matics analysis and luciferase assays to validate the direct
binding ability of the predicted miRNA response elements
on the full-length HOTAIR transcript. As expected, we dis-
covered miR-331-3p and miR-124 could form complemen-
tary base pairing with HOTAIR and induce translational
repression of a RLuc-HOTAIR reporter gene. In addition,
HOTAIR:miR-331-3P coimmunoprecipitation with anti-
Ago2 demonstrated a physical interaction in gastric cancer
cells, providing further support for HOTAIR’s miRNA-
sequestering activity. To serve as an endogenous ‘sponge’,
the abundance of HOTAIR should be comparable to or
higher than miR-331-3p/miR-124. In our study, qRT-PCR
analysis showed that miR-331-3p/miR-124 expression was
inversely correlated with HOTAIR expression in advanced
gastric cancer. Moreover, ectopic overexpression of miR-
331-3p or miR-124 expression could arrest gastric cancerproliferation, which was consistent with results of knock-
down of HOTAIR expression in gastric cancer cells. Taken
together, these data are consistent with our hypothesis and
indicate that HOTAIR may interact with miRNAs to link
miRNAs and the post-transcriptional network in gastric
pathogenesis.
To investigate the miRNA-related functions of HOTAIR
in gastric pathogenesis, we chose miR-331-3p as a model
miRNA for further studies, with a particular focus on the
target gene HER2. In carcinomas, HER2 acts as an onco-
gene, encoding a 185-kDa transmembrane protein to trig-
ger the activation of cell signaling networks, impacting on
various malignant cell functions such as proliferation, mo-
tility, angiogenesis and apoptosis [27-29]. HER2 amplifi-
cation and/or overexpression have been detected in
approximately 20% to 30% of patients with breast and
gastric cancer and correlates with poorer clinical out-
comes [19,30,31]. The importance of HER2 has been
well documented in breast cancer, where HER2 testing
is a standard approach for identifying patients who may
benefit from HER2-targeted agents such as lapatinib
and trastuzumab therapy in metastatic and adjuvant set-
tings [32,33]. In gastric cancer, HER2 overexpression is
associated with more aggressive disease and poor sur-
vival. Preclinical studies have indicated that trastuzu-
mab can impede HER2-overexpressing human gastric
cancer cells growth and inhibit tumorigenesis in xeno-
graft models [34-36]. Accumulating studies indicate that
HER2 overexpression may not be affected by gene amplifi-
cation alone, but is also likely to be influenced by transcrip-
tional activation and/or post-transcriptional mechanisms
in cancers [28,37]. In previous reports, HER2 mRNA
and protein overexpression have been directly affected
by miRNA-mediated post-transcriptional mechanisms
in carcinomas [38,39]. Our study also confirms that
HER2 is a direct target of miR-331-3p. Considering the
interaction of HOTAIR/miR-331-3p, we therefore hypo-
thesize that HOTAIR may also regulate HER2 expression
in gastric cancer, which signifies the role of HOTAIR in the
tumorigenesis-regulating network.
In this study, luciferase and RIP assays confirmed the ex-
istence of specific crosstalk between the lncRNA HOTAIR
and HER2 mRNA through competition for miR-331-3p
binding. Consistent with HOTAIR sequestration of miR-
331-3p, we found that its depletion reduced the expression
level of HER2, while its overexpression restored elevated
HER2 protein synthesis. These data are consistent with the
hypothesis that ceRNAs are transmodulators of gene ex-
pression through competing miRNA binding. Furthermore,
IHC and qRT-PCR assays revealed that HER2 was mainly
upregulated in advanced stage gastric cancer tissues or
those with lymph node metastasis, and associated with
high HOTAIR expression. Altogether, the positive correl-
ation between HOTAIR and HER2 expression and the
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miR-124) supports our hypothesis that ceRNA can se-
quester miRNAs, thereby protecting their target RNAs
from repression.
Lastly, the findings presented in this study have allowed
us to conclude that HOTAIR overexpression represents
an excellent biomarker of poor prognosis in gastric cancer,
and may confer multiple properties required for tumor
progression and metastatic phenotype. More importantly,
our study indicates that the ceRNA activity of HOTAIR
imparts a miRNA/lncRNA trans-regulatory function to
protein-coding mRNAs and the ceRNA network may play
an important role in gastric pathogenesis. Finally, our ex-
perimental data suggest that targeting the HOTAIR/HER2
interaction may represent a novel therapeutic application,
thus contributing to better knowledge of the efficacy and
tolerance of trastuzumab-based therapy in HER2-positive
gastric cancer patients.
It is worth mentioning that the ceRNA activity of
HOTAIR may sequester a handful of miRNAs at once,
while one miRNA is also capable of controlling multiple
genes. Therefore, the multiple properties of HOTAIR are
likely due to simultaneous targeting of multiple targets in
gastric cancer. We also hypothesize that there may be many
other lncRNAs that function as ceRNAs to regulate expres-
sion of key genes in gastric cancer. Thus, the identification
of these ceRNAs will undoubtedly enhance our knowledge
of how lncRNAs function, allowing us to better understand
the pathogenesis and development of gastric cancer and ul-
timately facilitate the development of lncRNA-directed
diagnostics and therapeutics against this deadly disease.
Materials and methods
Tissue collection
Fresh-frozen and paraffin-embedded gastric cancer tis-
sues and corresponding adjacent non-tumorous gastric
samples were obtained from Chinese patients at Jiangsu
province hospital between 2006 and 2008. All cases were
reviewed by pathologist and histologically confirmed as
gastric cancer (stageII,III,IV; 7th Edition AJCC) based on
histopathological evaluation. Clinical pathology informa-
tion was available for all samples (Table 1). No local or
systemic treatment was conducted in these patients before
the operation. The study was approved by the Research
Ethics Committee of Nanjing Medical University, China.
Informed consents were obtained from all patients.
Cell lines and culture conditions
Four gastric cancer cell lines (MGC-803, SGC-7901,
BGC-823, and AGS), a normal gastric epithelium cell line
(GES-1), a NSCLC cell line (SPC-A1), a normal human
bronchial epithelial cell line (16HBE), two breast cancer
cell lines (MCF-7, MDA-MB-231), and a human embry-
onic kidney cell line (HEK293T) were purchased from theInstitute of Biochemistry and Cell Biology of the Chinese
Academy of Sciences (Shanghai, China). Cells were cul-
tured in RPMI 1640 or DMEM (GIBCO-BRL) medium
supplemented with 10% fetal bovine serum (10% FBS),
100 U/ml penicillin, and 100 mg/ml streptomycin (Invi-
trogen) in humidified air at 37 °C with 5% CO2.
RNA extraction and qRT-PCR analyses
Total RNA was extracted from tissues or cultured cells
using TRIZOL reagent (Invitrogen, Carlsbad, Calif ). For
qRT-PCR, RNA was reverse transcribed to cDNA by using
a Reverse Transcription Kit (Takara, Dalian, China). Real-
time PCR analyses were performed with Power SYBR
Green (Takara, Dalian China). Results were normalized to
the expression of GAPDH. For miR-331-3p and miR-124
expression detection, reverse transcription was performed
following Applied Biosystems TaqMan MicroRNA Assay
protocol (Cat. # 4427975 and Cat. # 4427975). U6 snoRNA
was validated as the normalizer. The primers were listed in
Additional file 3: Table S4. qRT-PCR and data collection
were performed on ABI 7500.
Plasmid constructs
HOTAIR cDNA was cloned into the mammalian expres-
sion vector pcDNA3.1 (Invitrogen). To express miRNAs,
human microRNA precursors with about 80 bp of flank-
ing sequences in both sides were amplified and cloned
into the modified pLL3.7 vector (Invitrogen). To construct
luciferase reporter vectors, HER2 3’-UTR and HOTAIR
cDNA fragment containing the predicted potential micro-
RNAs binding sites were amplified by PCR, and then sub-
cloned downstream of the luciferase gene in the pLUC
luciferase vector (Ambion, Inc.,Austin, TX, USA). Primers
for subcloning and plasmid construction were listed in
Additional file 4: Table S3. We also designed shRNA se-
quence targeted HOTAIR as shown in Additional file 3:
Table S4. After annealing of the complementary shRNA
oligonucleotides, we ligated the annealed oligonucleotides
into pENTR vector (sh-HOTAIR).
Transfection of gastric cancer cells
All plasmid vectors for transfection were extracted by DNA
Midiprep kit (Qiagen, Hilden, Germany). Three individual
HOTAIR siRNAs (si-HOTAIR) and scrambled negative
control siRNA (si-NC) were purchased from Invitrogen
(Invitrogen, CA, USA). Target sequences for HOTAIR siR-
NAs were listed in Additional file 3: Table S4. The si-
HOTAIR, miR-331-3p or miR-124 was transfected into
BGC-823 cells respectively, and pCDNA/HOTAIR was
transfected into SGC-7901 cells using Lipofectamine2000
(Invitrogen) according to the manufacturer’s instructions.
At 48 h after transfection, cells were harvested for qRT-
PCR analyses or western blot.
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A cell proliferation assay was performed with MTT kit
(Sigma, St. Louis, Mo) according to the manufacturer’s
instruction. Cells were placed into 6-well plate and main-
tained in media containing 10% FBS for 2 weeks. Colonies
were fixed with methanol and stained with 0.1% crystal
violet (Sigma, St. Louis, Mo). Visible colonies were manu-
ally counted.
Flow-cytometric analysis of apoptosis
BGC-823 cells transiently transfected with si-NC or si-
HOTAIR were harvested 48 h after transfection by tryp-
sinization. After the double staining with FITC-Annexin
V and Propidium iodide (PI), the cells were analyzed with
a flow cytometry (FACScan®; BD Biosciences) equipped
with a CellQuest software (BD Biosciences).
Hoechst staining assay
BGC-823 cells transiently transfected with si-NC or si-
HOTAIR were cultured in six-well cell culture plates,
and Hoechst 33342 (Sigma, St Louis, MO, USA) was added
to the culture medium; changes in nuclear morphology
were detected by fluorescence microscopy using a filter for
Hoechst 33342 (365 nm). For quantification of Hoechst
33342 staining, the percentage of Hoechst-positive nuclei
per optical field (at least 50 fields) was counted.
Cell migration and invasion assays
At 48 h after transfection, cells in serum-free media
were placed into the upper chamber of an insert for mi-
gration assays (8-μm pore size, millepore) and invasion
assays with Matrigel (Sigma-Aldrich, USA). Media con-
taining 10% FBS was added to the lower chamber. After
several hours of incubation, the cells that had migrated or
invaded through the membrane were stained with metha-
nol and 0.1% crystal violet, imaged, and counted using an
IX71 inverted microscope (Olympus, Tokyo, Japan).
Tumor formation assay in a nude mouse model
5-week-old female athymic BALB/c mice were purchased
from the Model Animal Research Center of Nanjing
University. All animal procedures were performed in ac-
cordance to the protocols approved by the Institutional
Animal Care and Use Committee at the Nanjing Med-
ical University. For xenograft models, 5 × 106 BGC-823
cells transfected with sh-HOTAIR and pENTR vector (EV)
were injected subcutaneously in the right flank of BALB/c
nude mice (five mice per group). Tumor volumes were ex-
amined every 3 days when the implantations were starting
to grow bigger. After 16 days, these mice were sacrificed
and tumors were weighted. Tumor volumes were calcu-
lated by using the equation V (mm3) = A × B2/2, where A
is the largest diameter, and B is the perpendicular diameter.
The primary tumors were excised and tumor tissues wereused to perform qRT-PCR analysis of HOTAIR levels and
immunostaining analysis of proliferating cell nuclear anti-
gen (PCNA) protein expression.Bioinformatics methods
The potential microRNAs binding sites of HOTAIR pre-
dicted by computer-aided algorithms were obtained from
Segal Lab (http://132.77.150.113/pubs/mir07/mir07_predic
tion.html), RegRNA (http://regrna.mbc.nctu.edu.tw/html/
prediction.html) and microRNA.org-target program (www.
microRNA.org).Luciferase assay
Human HEK293Tcells (2.0 × 104) grown in a 96-well plate
were co-transfected with 150 ng of either empty vector or
miR-331-3p, miR-124, 50 ng of firefly luciferase reporter
comprising 3’UTR of HER2, wild type or mutant HOTAIR
fragment, and 2 ng of pRL-TK (Promega, Madison, WI,
USA) using Lipofectamie 2000 (Invitrogen, USA). rno-
miRNA-344 acts as a negative control. Cells were har-
vested 48 h after transfection for luciferase assay using a
luciferase assay kit (Promega) according to the manufac-
turer’s protocol. Transfection was repeated in triplicate.RNA Binding Protein Immunoprecipitation (RIP) assay
RNA immunoprecipitation was performed using the EZ-
Magna RIP kit (Millipore, Billerica, MA, USA) following
the manufacturer’s protocol. BGC-823 cells at 80-90%
confluency were scraped off, then lysed in complete RIP
lysis buffer, after which 100 μl of whole cell extract was
incubated with RIP buffer containing magnetic beads con-
jugated with human anti-Ago2 antibody (Millipore), nega-
tive control normal mouse IgG (Millipore). Anti-SNRNP70
(Millipore)was used as positive control for the RIP proced-
ure. Samples were incubated with Proteinase K with shak-
ing to digest the protein and then immunoprecipitated
RNA was isolated. The RNA concentration was measured
using a NanoDrop (Thermo Scientific) and the RNA qual-
ity assessed using a bioanalyser (Agilent, Santa Clara, CA,
USA). Furthermore, purified RNA was subjected to qRT-
PCR analysis to demonstrate the presence of the binding
targets using respective primers.Western blot assay and antibodies
Cells protein lysates were separated by 10% SDS-poly
acrylamide gel electrophoresis (SDS-PAGE), transferred to
0.22 μm NC membranes (Sigma) and incubated with
specific antibodies. Autoradiograms were quantified by
densitometry (Quantity One software; Bio-Rad). GAPDH
antibody was used as control, anti-HER2 (1:1000) and
cleaved caspase-3 (1:1,000) were purchased from Cell Sig-
naling Technology, Inc (CST).
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Paraffin-embedded, formalin-fixed tissues were immuno-
stained for HER2 and PCNA proteins. The signal was amp-
lified and visualized with diaminobenzidine-chromogen,
followed by counterstaining with hematoxylin. For HER2,
an IHC score of 2+ or more was defined as positive, and
IHC scores of 0 and 1+ were defined as negative [40]. Anti-
HER2 (1:50) was purchased from Cell Signaling Technol-
ogy, Inc. (CST), and anti-PCNA (1:50) was purchased from
Bioworld Technology, Inc., respectively.
Statistical analysis
Student’s t-test (two-tailed), One-way ANOVA and Mann–
Whitney test were performed to analyze the in vitro and
in vivo data using SPSS 16.0 software. P values less than
0.05 were considered significantly.
Additional files
Additional file 1: Figure S1. (A). MTT assay was performed to determine
the proliferation of pCDNA/HOTAIR transfected MGC803 and AGS cells. Data
represent the mean ± s.d. from three independent experiments. (B). Western
blot analysis of cleaved caspase-3 after si-HOTAIR transfection with BGC-823
cells. GAPDH was used as a control. *P < 0.05.
Additional file 2: Table S2. Immunostaining of HER2 protein in
advanced GC tissue samples.
Additional file 3: Table S4. Primers for qRT-PCR analyses and target
sequences for HOTAIR siRNAs or shRNA.
Additional file 4: Table S3. Primers for subcloning and plasmid
construction.
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